Evidence map›Paper›PMID 38337415›Full record

ReviewJournal of clinical medicine2024

To Be Frail or Not to Be Frail: This Is the Question-A Critical Narrative Review of Frailty.

Salvatore Sciacchitano, Valeria Carola, Giampaolo Nicolais, Simona Sciacchitano, Christian Napoli, Rita Mancini, Monica Rocco, Flaminia Coluzzi

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Association Between Health Literacy and Frailty in Older Adults: A Study in Two Brazilian Municipalities.International journal of environmental research and public health · 2026
    Article
  7. Review
  8. Risk aversion and time preference among elderly: does frailty matter?International journal of health economics and management · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. What Do We Know About Prevention of Frailty in Women?American journal of lifestyle medicine · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Salvatore SciacchitanoDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0003-1492-5365
Valeria CarolaDepartment of Dynamic and Clinical Psychology and Health Studies, Sapienza University of Rome, 00189 Rome, Italy.
Giampaolo NicolaisDepartment of Dynamic and Clinical Psychology and Health Studies, Sapienza University of Rome, 00189 Rome, Italy.
Simona SciacchitanoDepartment of Psychiatry, La Princesa University Hospital, 28006 Madrid, Spain.ORCID 0009-0006-6915-6582
Christian NapoliDepartment of Surgical and Medical Science and Translational Medicine, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0002-5775-2276
Rita ManciniDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.
Monica RoccoUnit of Anaesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0001-8380-3607
Flaminia ColuzziUnit of Anaesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0001-7184-5519
Hospital Universitario de La Princesa · ESSapienza University of Rome · IT

Funding

Italian Ministry of Health, Next Generation EU PNRR-MAD-12376767Sapienza University of Rome RG12117A5213378A
6 · The paper itself

Abstract

Many factors have contributed to rendering frailty an emerging, relevant, and very popular concept. First, many pandemics that have affected humanity in history, including COVID-19, most recently, have had more severe effects on frail people compared to non-frail ones. Second, the increase in human life expectancy observed in many developed countries, including Italy has led to a rise in the percentage of the older population that is more likely to be frail, which is why frailty is much a more common concern among geriatricians compared to other the various health-care professionals. Third, the stratification of people according to the occurrence and the degree of frailty allows healthcare decision makers to adequately plan for the allocation of available human professional and economic resources. Since frailty is considered to be fully preventable, there are relevant consequences in terms of potential benefits both in terms of the clinical outcome and healthcare costs. Frailty is becoming a popular, pervasive, and almost omnipresent concept in many different contexts, including clinical medicine, physical health, lifestyle behavior, mental health, health policy, and socio-economic planning sciences. The emergence of the new "science of frailty" has been recently acknowledged. However, there is still debate on the exact definition of frailty, the pathogenic mechanisms involved, the most appropriate method to assess frailty, and consequently, who should be considered frail. This narrative review aims to analyze frailty from many different aspects and points of view, with a special focus on the proposed pathogenic mechanisms, the various factors that have been considered in the assessment of frailty, and the emerging role of biomarkers in the early recognition of frailty, particularly on the role of mitochondria. According to the extensive literature on this topic, it is clear that frailty is a very complex syndrome, involving many different domains and affecting multiple physiological systems. Therefore, its management should be directed towards a comprehensive and multifaceted holistic approach and a personalized intervention strategy to slow down its progression or even to completely reverse the course of this condition.

Indexed as

agingepidemics/pandemicsfrailtyfrailty assessmentfrailty pathogenesisinterventionsmitochondrial dysfunctionrisk factors

Identifiers

PMID38337415
PMCPMC10856357
OpenAlexW4391251648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.